Yeah. So I think there's actually two stages of upside within the baseline outlook, right? So we're obviously playing it safe, looking at GM's track record of producing and selling these vehicles and their approach to Honda has been a little bit different, right? They've been producing mostly higher-end models, higher trim levels. And so that's why we cut our baseline outlook to 180,000 vehicles for GM, right? But if GM does get to their 200,000 vehicles level, for us, that could be a good $20 million of revenue upside during the year, right? And it could all fall in Q3 or Q4 or split out in various different ways. Like it's hard to determine how that would plan. Then there's the same element of the upside, which is whether they get to 250,000 right? And that would be another -- depending on the vehicle, that would be another 50 plus -- $50 million to $65 million of revenue upside depending on what vehicles they make, right? So they make more Equinoxes, it's on the lower end of that number. If they make more Hummers, Escalades, larger battery pack vehicles and our CPV would be higher. We just want to manage our business here and plan our expenses, not having to worry about whether GM goes to 225 or 190. We take our baseline guide very seriously. We think the planning internally pretty seriously. And it'd be great to just run our business without having to worry what GM is saying at some investor conference around their EV outlook, right? The other part that's worth mentioning is that we read the coverage of the OEMs and their messaging and right now, the market is incentivizing OEMs to say that they're producing less EVs because they perceive us an impact on their profitability, right? But at some point, EVs are really a driver of their sustainability as Acentia can sell vehicles, at least in the US and in in Europe, 2026 and beyond, right? And so I think people should not lose sight of that. And that's why while our long-term outlook is still very optimistic here in the near term, we just want to be careful with what we set our expectations of GM to produce.